HIGHLIGHTS
- who: Willem J.A. Witlox from the Department of Clinical and Medical Technology Assessment, Maastricht University Medical Centre (MUMC), The Netherlands have published the Article: Cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer, in the Journal: (JOURNAL)
- what: The aim of this study is to perform a cost-effectiveness analysis comparing PCI to no PCI in stage III NSCLC. costs were divided by the incremental QALYs to calculated the incremental cost-effectiveness ratio (ICER). No adverse event (AE) disutilities were applied to the model to capture negative health effects . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.